HIF‐1α up‐regulation is associated with adverse clinicopathological and biological factors in neuroblastomas
- 9 May 2012
- journal article
- Published by Wiley in Histopathology
- Vol. 61 (3) , 417-427
Abstract
Dungwa J V, Hunt L P & Ramani P (2012) Histopathology 61, 417–427 HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas Aims: To study the expression of hypoxia-inducible factor 1α (HIF-1α) in clinical neuroblastoma (NB) samples and its association with the clinicopathological features, biological features and survival of NB patients. Methods and results: Immunohistochemistry indicated that elevated HIF-1α expression was present in 30 of 90 (33%) NBs. This expression was correlated significantly and positively with higher clinical stage (P = 0.002), ≥18 months of age at presentation (P = 0.020), high-risk group (P = 0.005), unfavourable pathology (P = 0.002), MYCN amplification (P < 0.001), 1p deletion (P = 0.004) and 17q gain (P = 0.002). Enzyme-linked immunosorbent assays showed that total HIF-1α protein was significantly higher in NBs of patients with all examined adverse prognostic factors except for age. Univariate survival analysis revealed that higher-than-median HIF-1α total protein levels were associated significantly with a decrease in event-free survival (EFS) (P = 0.017), but not in overall survival (OS) (P = 0.12). HIF-1α immunoexpression by ≥10% of tumour cells was associated significantly with decreased OS and EFS (P = 0.002 and P = 0.004, respectively), but not in multivariate analysis after adjusting for the high-risk group (P = 0.16 and P = 0.19, respectively). Conclusions: HIF-1α was increased significantly in patients with NB associated with unfavourable characteristics. HIF-1α is a prognostic indicator of poor OS and EFS and defines subgroups of NBs with aggressive clinical behaviour.Keywords
This publication has 26 references indexed in Scilit:
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of MetastasisClinical Cancer Research, 2010
- Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1αCancer Research, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Molecular pathogenesis of peripheral neuroblastic tumorsOncogene, 2010
- A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patientsMolecular Cancer, 2010
- The Role of Myc-Induced Protein Synthesis in CancerCancer Research, 2009
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Development of HIF‐1 inhibitors for cancer therapyJournal of Cellular and Molecular Medicine, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Role of hypoxia-inducible factor-1α as a cancer therapy targetEndocrine-Related Cancer, 2006